Ceres Naturals, LLC, a licensed cannabis processor based in Frederick, Maryland, entered into a Consent Order with the Maryland Cannabis Administration (MCA) following a series of regulatory violations discovered during a surprise inspection. Operating under license number PA-23-00022 at 5330 Spectrum Drive, Suite H, the company was found in breach of multiple provisions of Maryland’s Cannabis Reform Act and associated regulations, including COMAR 10.62 and 14.17. The MCA conducted the unannounced inspection on September 18, 2023, which led to administrative charges being issued on October 24, 2024.
Improper Sublease Arrangement Raises Red Flags
At the center of the investigation was a lease agreement between Ceres Naturals and Patriot Medical Laboratories, operating as CIAN Diagnostics. Under the sublease, CIAN agreed to provide utilities and janitorial services for the cannabis processing facility. Although the lease had been disclosed to the MCA during the licensure inspection, the arrangement raised compliance concerns. The MCA determined that the agreement and resulting operational control did not align with required oversight and disclosure expectations under Maryland law. These concerns contributed to the Administration’s decision to issue formal charges.
Security and Visitor Log Failures Found
One of the most serious violations involved lapses in facility security protocols. According to COMAR 10.62.21.07, cannabis processors must maintain strict control over access to non-public areas, including logging visitors, supervising them at all times, and recording copies of their government-issued IDs. The inspection found that Ceres Naturals had failed to adhere to these standards. Visitors were not properly logged, ID copies were not retained, and continuous visual supervision was not maintained. These failures represent major breaches of security and raise the risk of product diversion or unauthorized access.
Cannabis Storage and Equipment Sanitation Out of Compliance
In addition to security concerns, the MCA cited the facility for improper cannabis handling and poor sanitation practices. Ceres Naturals did not segregate or dispose of outdated, adulterated, or damaged cannabis products according to COMAR 10.62.22.04, a critical regulation meant to protect consumer safety and maintain product integrity. The facility also lacked accurate logs documenting the cleaning, maintenance, and calibration of processing equipment, which is required under COMAR 10.62.22.05. These oversights suggest a pattern of operational neglect that could jeopardize product quality and regulatory standing.
Unregistered and Untrained Agents Operating On-Site
The investigation also revealed that some agents working at the facility were not properly registered with the MCA, violating COMAR 14.17.15.02. Moreover, the facility failed to adequately train its agents on state and federal cannabis laws, diversion prevention, and emergency procedures—key responsibilities under COMAR 14.17.15.05. The lack of training and registration posed risks to operational safety and compliance, undermining the credibility and legal standing of the processor’s workforce.
Consent Order Avoids Formal Hearing and Enforces Corrective Measures
In lieu of a formal hearing, Ceres Naturals agreed to resolve the matter by entering into a Consent Order with the MCA. Under the agreement, the company must rectify the violations, implement revised standard operating procedures, and submit to continued oversight by the Administration. The resolution reinforces the MCA’s authority under the Cannabis Reform Act to take enforcement actions including fines, suspensions, and revocations for noncompliance. This case underscores the importance of strict regulatory adherence for all cannabis businesses operating in Maryland’s expanding adult-use and medical cannabis markets.
